A synthetic analog of LYPRESSIN with a PHENYLALANINE substitution at residue 2. Felypressin is a vasoconstrictor with reduced antidiuretic activity.
Felypressin has been studied across 11 research domains including ❤️ Cardiovascular, 💊 Pain, 😴 Sleep, 🫘 Kidney, 🧠 Focus & Attention. The primary research focus is ❤️ Cardiovascular with 32% of studies addressing this area.
This evidence profile for Felypressin is generated deterministically from 110 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.